Recombinant Human FGF-19 Protein

Product Discontinued

Recombinant Human FGF-19 Protein Summary

• Description: Recombinant bioactive protein containing 195 amino acids for Human FGF-19
  
  

  Source:E. coli
  Amino Acid Sequence:(NM_005117)

• Details of Functionality: Determined by a cell proliferation assay using balb/c 3T3 cells. The expected ED50 for this effect is 50-200 ng/ml.
• Source: E. coli
• Protein/Peptide Type: Recombinant Protein
• Gene: FGF19
• Purity: >95%, by SDS-PAGE
• Endotoxin Note: <0.1 ng/ug

Applications/Dilutions

• Dilutions:
  • Bioactivity
  • SDS-Page
• Application Notes: The protein may appear as a haze or film, which may not be visible at the bottom of the vial.
• Theoretical MW: 21.8 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Packaging, Storage & Formulations

• Storage: Store at -20 to -80C. Avoid freeze-thaw cycles.
• Buffer: Lyophilized without additives.
• Concentration: Lyoph
• Purity: >95%, by SDS-PAGE
• Reconstitution Instructions: Reconstitute in H2O to a concentration of 0.1 - 1.0 ug/ul. This solution can then be diluted into other aqueous buffers and stored at 4C for 1 week or -20C for long-term storage.

Alternate Names for Recombinant Human FGF-19 Protein

• FGF19
• FGF-19
• fibroblast growth factor 19

Background

Fibroblast Growth Factor-19 (FGF-19) is a high affinity heparin dependent ligand for FGFR4. Recombinant human FGF-19 is an 21.8 kDa protein containing 195 amino acid residues.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: FGF19